Literature DB >> 10852963

MEK kinase 1 gene disruption alters cell migration and c-Jun NH2-terminal kinase regulation but does not cause a measurable defect in NF-kappa B activation.

T Yujiri1, M Ware, C Widmann, R Oyer, D Russell, E Chan, Y Zaitsu, P Clarke, K Tyler, Y Oka, G R Fanger, P Henson, G L Johnson.   

Abstract

MEK kinase 1 (MEKK1) is a 196-kDa mitogen-activated protein kinase (MAPK) kinase kinase that, in addition to regulating the c-Jun NH(2)-terminal kinase (JNK) pathway, is involved in the control of cell motility. MEKK1(-/-) mice are defective in eyelid closure, a TGFalpha-directed process involving the migration of epithelial cells. MEKK1 expression in epithelial cells stimulates lamellipodia formation, a process required for cell movement. In addition, mouse embryo fibroblasts derived from MEKK1(-/-) mice are inhibited in their migration relative to MEKK1(+/+) fibroblasts. MEKK1 is required for JNK but not NF-kappaB activation in response to virus infection, microtubule disruption, and stimulation of embryonic stem cells with lysophosphatidic acid. MEKK1 is not required for TNFalpha or IL-1 regulation of JNK or NF-kappaB activation in macrophages or fibroblasts. Thus, MEKK1 senses microtubule integrity, contributes to the regulation of fibroblast and epithelial cell migration, and is required for activation of JNK but not NF-kappaB in response to selected stress stimuli.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10852963      PMCID: PMC16535          DOI: 10.1073/pnas.130176697

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  Differentiation of CD4+ T cells to Th1 cells requires MAP kinase JNK2.

Authors:  D D Yang; D Conze; A J Whitmarsh; T Barrett; R J Davis; M Rincón; R A Flavell
Journal:  Immunity       Date:  1998-10       Impact factor: 31.745

Review 2.  The Rho GTPases in macrophage motility and chemotaxis.

Authors:  G E Jones; W E Allen; A J Ridley
Journal:  Cell Adhes Commun       Date:  1998

3.  Lung vascular injury induced by chemotactic factors: enhancement by bacterial endotoxins.

Authors:  G S Worthen; C Haslett; L A Smedly; A J Rees; R S Gumbay; J E Henson; P M Henson
Journal:  Fed Proc       Date:  1986-01

4.  MEK kinase 1 (MEKK1) transduces c-Jun NH2-terminal kinase activation in response to changes in the microtubule cytoskeleton.

Authors:  T Yujiri; G R Fanger; T P Garrington; T K Schlesinger; S Gibson; G L Johnson
Journal:  J Biol Chem       Date:  1999-04-30       Impact factor: 5.157

5.  MEKK1 interacts with alpha-actinin and localizes to stress fibers and focal adhesions.

Authors:  L B Christerson; C A Vanderbilt; M H Cobb
Journal:  Cell Motil Cytoskeleton       Date:  1999

6.  Synergistic enhansons located within an acute phase responsive enhancer modulate glucocorticoid induction of angiotensinogen gene transcription.

Authors:  A R Brasier; D Ron; J E Tate; J F Habener
Journal:  Mol Endocrinol       Date:  1990-12

7.  Role of MEKK1 in cell survival and activation of JNK and ERK pathways defined by targeted gene disruption.

Authors:  T Yujiri; S Sather; G R Fanger; G L Johnson
Journal:  Science       Date:  1998-12-04       Impact factor: 47.728

8.  MEKK1 activates both IkappaB kinase alpha and IkappaB kinase beta.

Authors:  F S Lee; R T Peters; L C Dang; T Maniatis
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

9.  Role of integrins in mouse eyelid development: studies in normal embryos and embryos in which there is a failure of eyelid fusion.

Authors:  J M Carroll; N C Luetteke; D C Lee; F M Watt
Journal:  Mech Dev       Date:  1998-11       Impact factor: 1.882

10.  Both N- and C-terminal domains of RelB are required for full transactivation: role of the N-terminal leucine zipper-like motif.

Authors:  P Dobrzanski; R P Ryseck; R Bravo
Journal:  Mol Cell Biol       Date:  1993-03       Impact factor: 4.272

View more
  79 in total

1.  MEKK1 regulates calpain-dependent proteolysis of focal adhesion proteins for rear-end detachment of migrating fibroblasts.

Authors:  Bruce D Cuevas; Amy N Abell; James A Witowsky; Toshiaki Yujiri; Nancy Lassignal Johnson; Kamala Kesavan; Marti Ware; Peter L Jones; Scott A Weed; Roberta L DeBiasi; Yoshitomo Oka; Kenneth L Tyler; Gary L Johnson
Journal:  EMBO J       Date:  2003-07-01       Impact factor: 11.598

2.  MEKK1 transduces activin signals in keratinocytes to induce actin stress fiber formation and migration.

Authors:  Lin Zhang; Maoxian Deng; Ranjani Parthasarathy; Lei Wang; Maureen Mongan; Jeffery D Molkentin; Yi Zheng; Ying Xia
Journal:  Mol Cell Biol       Date:  2005-01       Impact factor: 4.272

Review 3.  Uses for JNK: the many and varied substrates of the c-Jun N-terminal kinases.

Authors:  Marie A Bogoyevitch; Bostjan Kobe
Journal:  Microbiol Mol Biol Rev       Date:  2006-12       Impact factor: 11.056

4.  Interleukin-1 (IL-1) receptor-associated kinase-dependent IL-1-induced signaling complexes phosphorylate TAK1 and TAB2 at the plasma membrane and activate TAK1 in the cytosol.

Authors:  Zhengfan Jiang; Jun Ninomiya-Tsuji; Youcun Qian; Kunihiro Matsumoto; Xiaoxia Li
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

5.  Sphingosine 1-phosphate receptors are essential mediators of eyelid closure during embryonic development.

Authors:  Deron R Herr; Chang-Wook Lee; Wei Wang; Adam Ware; Richard Rivera; Jerold Chun
Journal:  J Biol Chem       Date:  2013-09-03       Impact factor: 5.157

6.  GRASP-1 is a neuronal scaffold protein for the JNK signaling pathway.

Authors:  Bing Ye; Wei-ping Yu; Gareth M Thomas; Richard L Huganir
Journal:  FEBS Lett       Date:  2007-08-14       Impact factor: 4.124

7.  MEKK1 Associated with Neuronal Apoptosis Following Intracerebral Hemorrhage.

Authors:  Hongjian Lu; Xiaojin Ning; Xuelei Tao; Jianbing Ren; Xinjian Song; Weidong Tao; Liang Zhu; Lijian Han; Tao Tao; Jianbin Yang
Journal:  Neurochem Res       Date:  2016-09-23       Impact factor: 3.996

8.  IkappaB kinase beta phosphorylates Dok1 serines in response to TNF, IL-1, or gamma radiation.

Authors:  Sanghoon Lee; Charlotte Andrieu; Frédéric Saltel; Olivier Destaing; Jessie Auclair; Véronique Pouchkine; Jocelyne Michelon; Bruno Salaun; Ryuji Kobayashi; Pierre Jurdic; Elliott D Kieff; Bakary S Sylla
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-01       Impact factor: 11.205

9.  Loss of SMEK, a novel, conserved protein, suppresses MEK1 null cell polarity, chemotaxis, and gene expression defects.

Authors:  Michelle C Mendoza; Fei Du; Negin Iranfar; Nan Tang; Hui Ma; William F Loomis; Richard A Firtel
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

10.  The MEKK1-JNK pathway plays a protective role in pressure overload but does not mediate cardiac hypertrophy.

Authors:  Junichi Sadoshima; Olivier Montagne; Qian Wang; Guiping Yang; Jill Warden; Jing Liu; Gen Takagi; Vijaya Karoor; Chull Hong; Gary L Johnson; Dorothy E Vatner; Stephen F Vatner
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.